- Home
- NVO vs TXN Comparison
NVO vs TXN Comparison
Compare NVO & TXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | TXN |
|---|---|---|
| Founded | 1923 | 1930 |
| Country | Denmark | United States |
| Employees | 69500 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.9B | 256.7B |
| IPO Year | N/A | 2002 |
Fundamental Metrics
Financial Performance| Metric | NVO | TXN |
|---|---|---|
| Price | $51.34 | $288.94 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 25 |
| Target Price | $51.00 | ★ $265.46 |
| AVG Volume (30 Days) | ★ 9.1M | 8.3M |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.19% | 2.11% |
| EPS Growth | N/A | ★ 4.81 |
| EPS | N/A | ★ 1.68 |
| Revenue | N/A | ★ $17,682,000,000.00 |
| Revenue This Year | N/A | $11.74 |
| Revenue Next Year | $3.70 | $10.43 |
| P/E Ratio | ★ $13.60 | $179.00 |
| Revenue Growth | N/A | ★ 13.05 |
| 52 Week Low | $35.12 | $152.73 |
| 52 Week High | $71.80 | $334.03 |
Technical Indicators
Market Signals| Indicator | NVO | TXN |
|---|---|---|
| Relative Strength Index (RSI) | 70.43 | 45.63 |
| Support Level | $50.55 | $274.83 |
| Resistance Level | $53.63 | $312.81 |
| Average True Range (ATR) | 1.04 | 12.90 |
| MACD | 0.12 | -1.04 |
| Stochastic Oscillator | 93.72 | 35.97 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About TXN Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.